Literature DB >> 23432859

Epidemiologic pattern of meningococcal meningitis in northern Cameroon in 2007-2010: contribution of PCR-enhanced surveillance.

Denis Massenet1, Jacques Birguel, François Azowé, Clifford Ebong, Bouba Gake, Jean-Pierre Lombart, Pascal Boisier.   

Abstract

OBJECTIVES: Monitoring acute bacterial meningitis in northern Cameroon.
METHODS: Health professionals collected cerebrospinal fluid (CSF) specimens from patients presenting with clinical symptoms of meningitis. Specimens were tested using gram stain, latex agglutination test, and culture. A PCR assay completed the diagnostic testing. Multilocus sequence typing (MLST) was performed on some Neisseria meningitidis (Nm) isolates.
RESULTS: From 2007 through 2010, of the 1429 CSF specimens tested, 292 (20·4%) were positive, either for Nm (205), Streptococcus pneumoniae (Sp) (57), or Haemophilus influenzae (Hi) (30). From 2007 through 2009, the serogroup W135 represented 98·8% of 164 case isolates. Until 2008, most serogroup W135 isolates presented the sequence-type ST-2881 usually associated with sporadic cases. Since 2009, the ST-11 (an epidemic-associated clone) became predominant, although no epidemic occurred. Serogroup A ST-7 was observed in 2010 and caused a localized epidemic. Using the detection PCR on turbid CSF, a 2·7-fold increase in cases with etiologic diagnosis was obtained, compared to culture. All tested meningococcal isolates (42) were susceptible to ampicillin, chloramphenicol, and cefotaxim.
CONCLUSIONS: Resurgence of serogroup A and recent increase in ST-11 among serogroup W135 isolates were worrying when considered with the epidemic wave of serogroup A meningitis, which affected neighboring countries and the serogroup W135 epidemic in Niger in 2009-2010.

Entities:  

Mesh:

Year:  2013        PMID: 23432859      PMCID: PMC4001598          DOI: 10.1179/2047773212Y.0000000070

Source DB:  PubMed          Journal:  Pathog Glob Health        ISSN: 2047-7724            Impact factor:   2.894


  19 in total

1.  [CEREBROSPINAL MENINGITIS IN AFRICA].

Authors:  L LAPEYSSONNIE
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

2.  Positive effect of the introduction of Haemophilus influenzae type b vaccination in the expanded program on immunization in Cameroon.

Authors:  Denis Massenet; Michèle Tapindjin-Gake
Journal:  Vaccine       Date:  2010-07-30       Impact factor: 3.641

3.  Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing.

Authors:  Isabelle Parent du Châtelet; Yves Traore; Bradford D Gessner; Aude Antignac; B Naccro; Berthe-Marie Njanpop-Lafourcade; Macaire S Ouedraogo; Sylvestre R Tiendrebeogo; Emmanuelle Varon; Muhammed K Taha
Journal:  Clin Infect Dis       Date:  2004-12-08       Impact factor: 9.079

4.  Meningitis in Chad, Niger and Nigeria: 2009 epidemic season.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2010-02-19

5.  Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms.

Authors:  M C Maiden; J A Bygraves; E Feil; G Morelli; J E Russell; R Urwin; Q Zhang; J Zhou; K Zurth; D A Caugant; I M Feavers; M Achtman; B G Spratt
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

6.  PCR for capsular typing of Haemophilus influenzae.

Authors:  T J Falla; D W Crook; L N Brophy; D Maskell; J S Kroll; E R Moxon
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

7.  Epidemic meningococcal meningitis, Cameroon.

Authors:  D Massenet; D Vohod; H Hamadicko; D A Caugant
Journal:  Emerg Infect Dis       Date:  2011-11       Impact factor: 6.883

8.  Increase in Neisseria meningitidis serogroup W135, Niger, 2010.

Authors:  Jean Marc Collard; Zaneidou Maman; Harouna Yacouba; Saacou Djibo; Pierre Nicolas; Jean Francois Jusot; Jocelyne Rocourt; Rabi Maitournam
Journal:  Emerg Infect Dis       Date:  2010-09       Impact factor: 6.883

9.  Polymerase chain reaction assay and bacterial meningitis surveillance in remote areas, Niger.

Authors:  Fati Sidikou; Saacou Djibo; Muhamed Kheir Taha; Jean Michel Alonso; Ali Djibo; Kiari Kaka Kairo; Suzanne Chanteau; Pascal Boisier
Journal:  Emerg Infect Dis       Date:  2003-11       Impact factor: 6.883

10.  Serogroup W135 meningococcal meningitis, Northern Cameroon, 2007-2008.

Authors:  Denis Massenet; Jermias Inrombe; Dave Etienne Mevoula; Pierre Nicolas
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883

View more
  5 in total

Review 1.  Rational development of guidelines for management of neonatal sepsis in developing countries.

Authors:  Anna C Seale; Christina W Obiero; James A Berkley
Journal:  Curr Opin Infect Dis       Date:  2015-06       Impact factor: 4.915

2.  Global etiology of bacterial meningitis: A systematic review and meta-analysis.

Authors:  Anouk M Oordt-Speets; Renee Bolijn; Rosa C van Hoorn; Amit Bhavsar; Moe H Kyaw
Journal:  PLoS One       Date:  2018-06-11       Impact factor: 3.240

3.  Loss of Genomic Diversity in a Neisseria meningitidis Clone Through a Colonization Bottleneck.

Authors:  Araceli Lamelas; Abdul-Wahab M Hamid; Jean-Pierre Dangy; Julia Hauser; Maja Jud; Katharina Röltgen; Abraham Hodgson; Thomas Junghanss; Simon R Harris; Julian Parkhill; Stephen D Bentley; Gerd Pluschke
Journal:  Genome Biol Evol       Date:  2018-08-01       Impact factor: 3.416

4.  Neuroscience education and research in Cameroon: Current status and future direction.

Authors:  Ngala Elvis Mbiydzenyuy; Constant Anatole Pieme; Richard E Brown; Carine Nguemeni
Journal:  IBRO Neurosci Rep       Date:  2021-03-05

5.  Emergence and genomic diversification of a virulent serogroup W:ST-2881(CC175) Neisseria meningitidis clone in the African meningitis belt.

Authors:  Araceli Lamelas; Julia Hauser; Jean-Pierre Dangy; Abdul-Wahab M Hamid; Katharina Röltgen; Mohamad R Abdul Sater; Abraham Hodgson; Ali Sie; Thomas Junghanss; Simon R Harris; Julian Parkhill; Stephen D Bentley; Gerd Pluschke
Journal:  Microb Genom       Date:  2017-06-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.